Image 1 (D95f9b1b F1e4 4ae4 A215 7317fb1ca565 01)
Divalproex Sodium Tablet, Extended Release
Product Images NDC 71335-1883
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Divalproex Sodium (NDC 71335-1883). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Image 2 (D95f9b1b F1e4 4ae4 A215 7317fb1ca565 02)
The text is a chart or graph depicting the percentage reduction in CPS (Central Nervous System) rate for patients taking Divalproex Sodium Delayed-Release medication versus those taking a placebo. The chart shows a 50% improvement in patients taking the medication, with no change or worsening in some patients.*
Image 3 (D95f9b1b F1e4 4ae4 A215 7317fb1ca565 03)
Image 4 (D95f9b1b F1e4 4ae4 A215 7317fb1ca565 04)
Label (Lbl713351883)
This is a label of Divalproex Sodium ER tablets, 500mg strength. They are packaged by Buyant Ranch and manufactured by Lupin Limited. The tablets should be kept at room temperature and stored in a tightly closed container. The label includes information about quantity, expiry date, and National Drug Code (NDC) number.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
